6190 · PhoenixBio Co.,Ltd. · Financials
Market Cap
1.02B JPY
Shares
4.07M
Volume · Nov 11
5400
Avg daily vol (3M)
10.2K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.57B
+1.6%
FY2026
Net Income
125.23M
+127.9%
FY2026
Gross Margin
76.69%
+4.2pp
FY2026
Operating Margin
5.29%
+14.5pp
FY2026
Operating Cash Flow
68.86M
+194.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 1.57B | 1.54B | 1.72B | 2.12B | 1.32B |
| JPY | 364.93M | 423.69M | 520.26M | 567.6M | 597.03M |
| JPY | 1.2B | 1.12B | 1.2B | 1.56B | 727.79M |
| JPY | 82.77M | -142.08M | 11.06M | 508.45M | -167.62M |
| JPY | 131.44M | -432.84M | 59.79M | 510.64M | -393M |
| JPY | 6.21M | 16.09M | 33.41M | 17.31M | -5.03M |
| JPY | 125.23M | -448.93M | 26.38M | 493.33M | -387.97M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.